Screener
EBITDA at other companies
Other financials
Where this comes from
Calculated from West Pharmaceutical Services’s reported figures.
The source filing: West Pharmaceutical Services’s 10-Q, filed July 23, 2026. Open the filing →
- Filed
- Jul 23, 2026, 4:15 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000105770-26-000099
FAQ
- What is West Pharmaceutical Services's EBITDA?
- West Pharmaceutical Services (WST) reported EBITDA of $225.3M in Q2 2026.
- How has West Pharmaceutical Services's EBITDA changed year-over-year?
- West Pharmaceutical Services's EBITDA increased by 15.5% year-over-year, from $195.1M to $225.3M.
- What is the long-term trend for West Pharmaceutical Services's EBITDA?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's EBITDA has grown at a -3.4% compound annual growth rate (CAGR), from $869.4M to $755.7M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about West Pharmaceutical Services's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude